Jul 19, 2022
Prestigious CDMRP award will advance development of ORP100S as an inhaled treatment for acute and chronic respiratory diseases
SAN DIEGO - July 19, 2022 - PRLog -- OrPro Therapeutics, Inc., a San Diego Johnson & Johnson JLABS alumni and 2022 SD CONNECT Cool Company, is pleased to announce that it has been awarded a Fiscal Year 2021 (FY21) Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development grant under the Congressionally Directed Medical Research Program (CDMRP) of the US Department of Defense. This $2.147M award entitled "Development of Monothiol Human Thioredoxin-1 (ORP100S) as an Inhaled Treatment for Acute Viral Lung Injury" involves OrPro researchers and collaborators at the Institute for Airway Sciences in the Icahn School of Medicine at Mount Sinai (New York, NY), Lovelace Biomedical (Albuquerque, NM), and KCAS Bioanalytical Services (Olathe, KS). Project advisors include innate immunity opinion leader Dr. Richard Ulevitch, Professor and former Chair of the Department of Immunology at Scripps Research; 3-D stem cell derived human lung organoid pioneer Dr. Ya-Wen Chen at Mount Sinai; and internationally recognized inhalation toxicology expert Dr. Jeffrey Tepper.
The objective of the grant-funded research is to understand the pharmacodynamic effect of ORP100S in vitro and in vivo for treatment of relevant viral diseases (COVID-19 and influenza), as well as to establish a validated bioanalytical method for the detection and quantification of ORP100S in plasma/serum and lung matrices from humans and non-clinical toxicology species. These objectives represent key ORP100S development milestones toward a US FDA Investigational New Drug (IND) filing and human clinical trials.
"CDMRP funding is highly competitive. Our team is tremendously excited to be recognized by the Department of Defense for the potential of our drug platform to impact respiratory health by filling a critical gap in the prevention of lung injury associated with viral infection and inflammation," said Dr. Peter Heifetz, Founder, President and CEO of OrPro Therapeutics. "This award will enable us to rapidly advance ORP100S for multiple indications with high unmet medical need."
"Our 3-D human lung organoid system has been proven to accurately recapitulate respiratory viral infection and host responses, making it ideal for evaluation of the efficacy and mechanism of novel therapeutics. I am looking forward to working with Principal Investigator Dr. Heifetz and the project team to combine our in vitro human system with parallel in vivo studies in relevant animal infection models, said Dr. Ya-Wen Chen, Assistant Professor, Icahn School of Medicine at Mount Sinai. "This dual approach has great promise for enabling successful translation to clinical studies."
Thioredoxin
Secreted human thioredoxin (TRX) is a target-selective thiol-disulfide exchange enzyme that acts homeostatically to modulate inflammatory cytokine release, oxidative stress, and abnormal airway mucus viscoelasticity via regulatory interaction with extracellular cell-surface protein disulfides. TRX lowers inflammation in acute lung injury, and published studies show it can prevent viral pneumonia and increase survival in influenza-infected animal models. OrPro has developed the proprietary Theradux® platform of TRX derivatives optimized for extracellular delivery and function with increased half-life and decreased potential for intracellular uptake and off-target activity. Lead development candidate ORP100S is highly active extracellularly as a cell protectant without promoting cellular proliferation and is being advanced as an inhaled nebulized solution for treatment of acute and chronic obstructive/inflammatory airway diseases.
About OrPro Therapeutics
OrPro Therapeutics, Inc is a privately held preclinical-stage company pioneering a novel biologic drug platform for treating severe respiratory, ophthalmic, and mucosal diseases. The company's differentiated approach targets both lung clearance and inflammation as well as obstructive/inflammatory disorders associated with non-respiratory mucosal surfaces in the body. Launched in 2013 with technology in-licensed from National Jewish Health, the leading US respiratory research center, the company has secured Series A financing and significant non-dilutive grant funding from the National Institutes of Health and the Cystic Fibrosis Foundation with over $7M raised to date. For more information visit www.orprotherapeutics.com.
Contact
Peter Heifetz, Ph.D. OrPro Therapeutics, Inc. [email protected];
Media: Joleen Schultz, [email protected]; 760-271-8150
This is the 90th instalment in a biweekly series profiling major Hong Kong pop culture figures of recent decades. For much of the 2000s, Linda Chung Ka-yan was the patron saint of Hong Kong television’s tear-jerkers. With an unblemished girl-next-door persona and a sweet, high-pitched voice, the Hong Kong-Canadian actress was TVB’s most reliable good girl – a beauty pageant winner fast-tracked into a gruelling production factory. Yet beneath the halo of her affectionate “People’s Best Actress”...
Walker Scobell may be the titular star of Percy Jackson and the Olympians, but it’s his father, Pete Scobell, who’s stealing the spotlight. During the 17-year-old actor’s recent appearance on Good Morning America, fans caught a glimpse of the older Scobell proudly watching his son being interviewed. Now the internet is convinced he should play Walker’s on-screen father, Poseidon, thanks to his sharp appearance evoking that of a Greek god. His status as a military veteran is only amplifying his...
Leather has long been a favourite when it comes to our wardrobes, coveted for its luxurious feel, which becomes softer and more supple with time – but in the world of jewellery it has usually played a secondary role. Thanks to a number of daring brands, however, that’s beginning to change, with recent launches giving leather a starring role in the design of a piece through techniques such as braiding and beadwork, set against polished gold and extraordinary stones. Proof comes courtesy of...
LATAM’s first Airbus A321XLR arrives in March 2027, featuring 12 private business class suites, upgraded economy seating and personal entertainment screens, with potential new transatlantic routes from Brazil under consideration. The post Photos: LATAM Airlines Unveils A321XLR Cabin With 12 Private Suites appeared first on Business Traveller.
"The massive gaps in public bathroom stalls. You can see an entire person and all their shame through those gaps." View Entire Post ›
4/5 stars Of all the characters ripe for a spin-off in Quentin Tarantino’s cinematic universe, the choice has turned out to be Cliff Booth. While other concepts have been floated – notably his proposed-but-never-made film The Vega Brothers, featuring Michael Madsen’s Reservoir Dogs killer and John Travolta’s Pulp Fiction hitman – Cliff, the stuntman who fights Bruce Lee in Tarantino’s 2019 alt-history Once Upon a Time in Hollywood, is the one who made the cut. And rightly so: he is cool with a...
As an election nears, a railway disaster in Spain has set off debate over whether maintenance of its infrastructure kept pace with its booming population.
Delano Miami Beach’s legendary Rose Bar returns with sophisticated cocktails, indulgent bites and understated glamour, breathing fresh life into one of South Beach’s most storied gathering places for discerning drinkers. The post Bar Review: Rose Bar, Miami Beach – Inside the Comeback of a South Beach Icon appeared first on Business Traveller.
The team behind Buenos Aires’ celebrated Don Julio brings Argentine culinary traditions to Greenwich Village, where exceptional beef, handmade empanadas, seasonal ingredients and carefully selected wines capture Argentina’s gastronomic spirit. The post Restaurant Review: Graciela, New York – Buenos Aires Culinary Traditions in Manhattan appeared first on Business Traveller.
From Norfolk to London, Northumberland to Bristol, English whisky is enjoying a renaissance – and a new legal protection too. But what does it mean and where can you discover the category? The post English Whisky’s New Protected Status is Causing a Stir. Here’s Why – And Where to Try it appeared first on Business Traveller.
From Norfolk to London, Northumberland to Bristol, English whisky is enjoying a renaissance – and a new legal protection too. But what does it mean and where can you discover the category? The post English Whisky’s New Protected Status is Causing a Stir. Here’s Why – And Where to Try it appeared first on Business Traveller.
Vergessen Sie den Gedanken, im Namen des Wohlbefindens auf Wein verzichten zu müssen. Ob Hautpflegeprodukte auf Weinbasis, die aus Überresten der Weinproduktion gewonnen werden, oder von Trauben inspirierte Badezusätze – immer mehr Beauty-Marken entdecken, dass Wein und Wellness hervorragend zusammenpassen. The post Ist Wein gut für die Haut? Diese Beauty-Marken sind davon überzeugt appeared first on Business Traveller.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.